Here are eight takeaways:
1. In 2012, the market was valued at $6.1 billion.
2. By the end of 2019, the market is projected to reach $8.28 billion.
3. The rising prevalence of sports-related injuries is the market’s primary driver.
4. More cost-effective treatment, a growing geriatric population and more disposable income are fueling market growth.
5. Developed economies’ unfavorable reimbursement for sports-related injuries poses as a barrier to market growth.
6. Arthroscopy devices reached $1.59 billion in 2012. This segment of the market is expected to grow at a compound annual growth rate of 5.8 percent from 2013 to 2019.
7. North America led revenue in the market in 2010 with a net worth of $2.48 billion.
8. Market players include Zimmer, Wright Medical Technology, Stryker, Smith & Nephew, Skins International Trading, OttoBock Healthcare, Ossur, Mueller Sports Medicine, DJO Global, Conmend, BREG, Biomet, ArthroCare, Arthrex and 3M Ace Brand.
More articles on devices:
Dr. David Fischer auctioning off signed 1992 Olympic Men’s Basketball Dream Team poster & shoes
Dr. Bryan Kelly performs hip surgery on NY Rangers’ Oscar Lindberg: 5 points
Dr. Richard Parker performs surgery on Washington Wizards’ John Wall knees: 6 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
